Navamedic ASA (OSL:NAVA)
21.40
-0.90 (-4.04%)
Dec 2, 2025, 4:01 PM CET
Navamedic ASA Revenue
Navamedic ASA had revenue of 138.92M NOK in the quarter ending September 30, 2025, with 12.89% growth. This brings the company's revenue in the last twelve months to 539.42M, up 2.64% year-over-year. In the year 2024, Navamedic ASA had annual revenue of 531.44M with 3.80% growth.
Revenue (ttm)
539.42M
Revenue Growth
+2.64%
P/S Ratio
0.99
Revenue / Employee
12.84M
Employees
42
Market Cap
534.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 531.44M | 19.44M | 3.80% |
| Dec 31, 2023 | 512.00M | 129.86M | 33.98% |
| Dec 31, 2022 | 382.14M | 103.70M | 37.24% |
| Dec 31, 2021 | 278.44M | 68.56M | 32.67% |
| Dec 31, 2020 | 209.88M | 21.12M | 11.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 662.18M |
| Nordhealth AS | 590.33M |
| Photocure ASA | 537.59M |
| Omda AS | 476.29M |
| Vistin Pharma ASA | 455.25M |
| Gentian Diagnostics ASA | 172.52M |
| ContextVision AB | 115.15M |
| ArcticZymes Technologies ASA | 109.99M |